SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing a massive surge as investors react to a significant earnings beat and raised guidance that validates the company's aggressive turnaround strategy and AI data center growth. The stock's parabolic move has sparked intense community debate, with bulls celebrating a long-awaited comeback while shorts face extreme pressure amidst intense speculation over potential squeezes and institutional rotation into the semiconductor sector.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors react to the appointment of a new CEO for its Tanbreez project and the recent consolidation of majority ownership in the Greenland-based rare earth asset. Community discussion is heavily focused on the company's strategic position in the Western critical minerals supply chain, with many debating the impact of recent institutional capital raises and speculating on future price performance as the project moves toward operational development.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD shares are surging in sympathy with Intel's earnings beat, as investors rotate capital into semiconductor stocks amid a broader rally in the AI hardware sector. The community is sharply divided, with bulls celebrating an explosive momentum-driven melt-up, while bears caution that the recent parabolic move and rapid sentiment shift signals potential blow-off top conditions.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing a surge in investor interest and extreme trading volume, fueled by confirmed purchase orders from Marvell and widespread speculation regarding its role in the AI data center supply chain. The community is actively discussing the companys transition from early-stage R&D to commercial manufacturing, with shareholders fiercely debating the valuation against the backdrop of an aggressive short squeeze.

Skillz, Inc. operates a mobile gaming platform that connects players in competition. It helps developers build franchises by enabling social competition in their games. Skillz hosts casual esports tournaments for mobile players worldwide. The company was founded by Andrew C Paradise and Casey Chafkin in 2012 and is headquartered in Las Vegas, NV.

Skillz Inc - Ordinary Shares - Class A

Skillz Inc

Skillz Inc. is experiencing extreme volatility and heavy retail interest following a major legal victory against Papaya Gaming, where a jury awarded the company hundreds of millions in damages with further potential disgorgements pending. While bulls are anticipating a massive short squeeze similar to past momentum plays, the community remains divided between those expecting a continued rally toward triple digits and skeptics who are wary of potential dilution or difficulties in actualizing the legal settlement.

ASGN Incorporated engages in the provision of information technology services and solutions. It operates through the Commercial and Federal Government segments. The Commercial segment involves the provision of consulting, creative digital marketing, and permanent placement services. The Federal Government segment provides mission-critical solutions. The company was founded on December 30, 1985 and is headquartered in Glen Allen, VA.

ASGN Inc

ASGN Inc. is trending as investors digest a significant price decline following disappointing quarterly earnings and guidance. Community sentiment is deeply polarized, with some traders viewing the pullback as a buying opportunity based on the company's valuation and pending rebrand to Everforth, while others are calling for regulatory investigations into alleged market manipulation and poor financial performance.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Georgetown, TX.

TSS Inc

TSS Inc. is trending as investors react to a blowout earnings report featuring significantly higher-than-expected revenue and EPS, alongside a critical two-year contract extension with Dell. The community is actively discussing the stock's potential for a major breakout, focusing on the company's vital role in AI data center rack integration and its ability to capture market share amid industry consolidation.

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Cingulate Inc

Cingulate Inc. is trending as investors react to a significant US patent allowance for its Precision Timed Release technology, fueling speculation about the company's valuation ahead of a late-May PDUFA date for its ADHD treatment. While the community is actively debating the potential for a sharp price surge and long-term upside, discussions are heavily split between optimistic bulls anticipating a rapid breakout and cautious bears highlighting volatility and the risks associated with manufacturing questions and binary regulatory outcomes.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is surging amid high trading volume as investors react to strengthening technical signals and persistent buyout speculation surrounding the company's Briumvi commercial progress. The community remains focused on potential M&A activity and upcoming clinical readouts, with many traders discussing the stock's positioning against recent sector-wide deals and CEO Michael Weisss performance-based incentives.

Maulcoin

Maulcoin is trending as the community actively discusses token burn initiatives and collective holding strategies to build momentum. Investors are debating the project's long-term viability against rival meme tokens while emphasizing loyalty to the original developer.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pulmonx (LUNG) Projected to Post Earnings on Wednesday

Pulmonx (NASDAQ:LUNG) will be releasing its Q1 2026 earnings after the market closes on Wednesday, April 29. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-29-pulmonx-co-stock...

Pulmonx Corporation (NASDAQ:LUNG) Short Interest Update

Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) saw a significant drop in short interest in the month of March. As of March 31st, there was short interest totaling 2,857,097 shares, a drop of...

Hims & Hers Health (HIMS) Soars 11.1%: Is Further Upside Left in the Stock?

Hims & Hers Health (HIMS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Pulmonx (NASDAQ:LUNG) Stock Price Up 2.3%  - Still a Buy?

Pulmonx (NASDAQ:LUNG) Shares Up 2.3% - Time to Buy...

Pulmonx Corporation (NASDAQ:LUNG) Given Consensus Recommendation of "Hold" by Analysts

Shares of Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) have earned a consensus recommendation of "Hold" from the eight research firms that are presently covering the stock, MarketBeat Ratings...

TruBridge (TBRG) Beats Q4 Earnings Estimates

TruBridge (TBRG) delivered earnings and revenue surprises of +92.68% and -0.50%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Pulmonx Corporation (NASDAQ:LUNG) Given Average Rating of "Hold" by Brokerages

Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) has received an average recommendation of "Hold" from the eight research firms that are covering the firm, Marketbeat.com reports. One investment...

Pulmonx (NASDAQ:LUNG) Price Target Cut to $5.00 by Analysts at Canaccord Genuity Group

Canaccord Genuity Group lowered their price target on Pulmonx from $6.00 to $5.00 and set a "buy" rating for the company in a research report on Thursday...

Pulmonx (NASDAQ:LUNG) CEO Sells $96,972.59 in Stock

Pulmonx Corporation (NASDAQ:LUNG - Get Free Report) CEO Glendon French III sold 67,813 shares of the stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price...

Pulmonx (NASDAQ:LUNG) Issues Quarterly Earnings Results

Pulmonx (NASDAQ:LUNG - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.25) earnings per share for the quarter, topping analysts' consensus estimates of...

Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, Africa, Asia Pacific, and Other International segments. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.

Current Price	$1.28
Prev Close	$1.30
Open	$1.30
Dividend Yield	0.00%
50-Day Moving Average	$1.46
Beta	1.14
Avg. Volume	792,589.07
PE Ratio	-0.96

52-Week High	$5.46
52-Week Low	$1.13
Market Capitalization	$54.91M
EPS (Annual)	-$1.33
Price to Book	0.99
Revenue Per Employee	$305,733.11

LUNG
Pulmonx Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LUNG News

LUNGPulmonx Corp